Tempus to receive up to $9.5 million in ARPA-H ADVOCATE funding
Tempus AI, Inc. said it has been selected by ARPA-H to receive an award of up to $9.5 million to build the first autonomous clinical AI agent for cardiology.
Tempus AI, Inc. (NASDAQ: TEM) said it has been selected by the Advanced Research Projects Agency for Health, or ARPA-H, an agency within the U.S. Department of Health and Human Services, for an award of up to $9.5 million. The funding is for ADVOCATE, described as the first autonomous clinical AI agent capable…